Home » Stocks » Exactus

Exactus Inc. (EXDI)

Stock Price: $0.0500 USD 0.0000 (0.00%)
Updated Oct 16, 2020 9:30 AM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.60M
Revenue (ttm) 1.56M
Net Income (ttm) -11.68M
Shares Out 51.91M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 16, 2020
Last Price $0.0500
Previous Close $0.0500
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.0500
Day's Range 0.0500 - 0.0500
Day's Volume 0
52-Week Range 0.0403 - 0.8518

More Stats

Market Cap 2.60M
Enterprise Value 3.60M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 51.91M
Float 39.00M
EPS (basic) -0.30
EPS (diluted) -0.27
FCF / Share -0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 5.33
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.67
PB Ratio 1.56
Revenue 1.56M
Operating Income -11.47M
Net Income -11.68M
Free Cash Flow -2.82M
Net Cash -1.00M
Net Cash / Share -0.02
Gross Margin -93.13%
Operating Margin -736.56%
Profit Margin -749.80%
FCF Margin -180.95%
ROA -110.78%
ROE -486.69%
ROIC -270.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$12.80*
Low
12.8
Current: $0.0500
High
12.8
Target: 12.80
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue0.35------
Revenue Growth-----33.33%-
Gross Profit-1.70------
Operating Income-10.88-2.44-3.12-1.60-0.39-0.42-0.11
Net Income-9.69-4.34-3.86-1.60-0.36-0.30-0.02
Shares Outstanding33.904.764.240.300.010.010.01
Earnings Per Share-0.30-0.91-0.91-5.12-44.80-37.87-
Operating Cash Flow-5.75-0.47-1.23-0.89-0.64-0.40-
Capital Expenditures-0.54-----0.01-
Free Cash Flow-6.29-0.47-1.23-0.89-0.64-0.41-
Cash & Equivalents0.100.000.161.060.070.040.25
Total Debt0.630.640.11-0.10--
Net Cash / Debt-0.53-0.640.061.06-0.030.040.25
Assets8.020.010.172.130.080.080.28
Liabilities4.133.442.390.620.180.040.09
Book Value4.43-3.42-2.221.50-0.090.050.19
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Exactus Inc.
Country United States
CEO Emiliano Aloi

Stock Information

Ticker Symbol EXDI
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: EXDI

Description

Exactus produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.